|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.6750 GBX | 0.00% |
|
0.00% | +28.57% |
| Market Cap | 5.62M 7.58M 6.56M 6.12M 10.57M 722M 10.73M 71.85M 28.2M 362M 28.47M 27.85M 1.2B | P/E 2024 |
-1.69x | P/E 2025 | -3.09x |
|---|---|---|---|---|---|
| Enterprise Value | 4.54M 6.12M 5.3M 4.95M 8.54M 583M 8.67M 58.05M 22.78M 292M 23M 22.5M 966M | EV / Sales 2024 |
198,657,512x | EV / Sales 2025 | 452,941,079x |
| Free-Float |
41.35% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Thalia Therapeutics Plc
| 1 month | +3.85% | ||
| 3 months | +17.39% | ||
| 6 months | +42.11% | ||
| Current year | +28.57% |
| 1 week | 0.65 |  | 0.7 |
| 1 month | 0.6 | | 0.75 |
| Current year | 0.4 | | 0.95 |
| 1 year | 0.4 | | 1 |
| 3 years | 0.35 | | 1.7 |
| 5 years | 0.35 | | 10.12 |
| 10 years | 0.35 | | 35.7 |
| Manager | Title | Age | Since |
|---|---|---|---|
David Solomon
CEO | Chief Executive Officer | 66 | 24/02/2026 |
Rachel Schiller
COO | Chief Operating Officer | - | - |
Fiona McLaughlin
CTO | Chief Tech/Sci/R&D Officer | 56 | 27/05/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Luke Cairns
BRD | Director/Board Member | 48 | 14/07/2020 |
| Chairman | 59 | 01/08/2023 | |
| Director/Board Member | 81 | 09/09/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 28/11/24 | Free | Founder | 6,000,000 | 1.5198% | ||
| 28/11/24 | Free | Director | 3,000,000 | 0.7599% | ||
| 28/11/24 | Free | Chairman | 3,000,000 | 0.7599% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | 0.00% | +50.00% | -57.81% | 7.56M | |
| +8.49% | +23.38% | +65.44% | +104.90% | 62.92B | |
| +1.25% | +2.44% | +32.55% | +72.63% | 54.32B | |
| +1.65% | +2.31% | -16.78% | -5.92% | 22.91B | |
| -2.34% | +30.92% | +18.11% | +490.26% | 28.73B | |
| +10.83% | +21.32% | +45.03% | +2.02% | 21.65B | |
| +6.50% | +7.56% | +38.20% | -21.33% | 17.76B | |
| -3.88% | +20.98% | +201.07% | +350.94% | 16.47B | |
| +6.20% | +12.16% | +28.51% | +629.05% | 15.48B | |
| +3.12% | +1.31% | +43.69% | +165.31% | 13.12B | |
| Average | +3.15% | +6.68% | +50.58% | +173.01% | 25.34B | |
| Weighted average by Cap. | +3.90% | +9.95% | +47.37% | +165.16% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 0.01 0.01 0.01 0.01 0.01 0.94 0.01 0.09 0.04 0.47 0.04 0.04 1.55 | 0.01 0.01 0.01 0.01 0.01 0.93 0.01 0.09 0.04 0.47 0.04 0.04 1.55 |
| Net income | -1.06M -1.43M -1.24M -1.15M -1.99M -136M -2.02M -13.54M -5.31M -68.15M -5.36M -5.25M -225M | -1.21M -1.63M -1.41M -1.31M -2.27M -155M -2.3M -15.41M -6.05M -77.57M -6.11M -5.97M -256M |
| Net Debt | -626K -845K -731K -682K -1.18M -80.4M -1.2M -8.01M -3.14M -40.3M -3.17M -3.1M -133M | -1.08M -1.46M -1.26M -1.18M -2.03M -139M -2.06M -13.8M -5.42M -69.48M -5.47M -5.35M -230M |
Employees
3
| Date | Price | Change | Volume |
|---|---|---|---|
| 07/08/26 | GBX 0.6750 | 0.00% | 195,692 |
| 06/08/26 | GBX 0.6750 | 0.00% | 81,802 |
| 05/08/26 | GBX 0.6750 | 0.00% | 74,667 |
| 04/08/26 | GBX 0.6750 | 0.00% | 202,941 |
| 03/08/26 | GBX 0.6750 | 0.00% | 238,579 |
- Stock Market
- Stocks
- THAT Stock
Select your edition
All financial news and data tailored to specific country editions
